Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-04-30T17:27:00.230Z Has data issue: false hasContentIssue false

Chapter 1 - Oral Agents for Ovarian Stimulation

from Section 1 - Mild Forms of Ovarian Stimulation

Published online by Cambridge University Press:  14 April 2022

By
Mohamed F. Mitwally  and
Robert F. Casper
Edited by
Mohamed Aboulghar  and
Botros Rizk
Mohamed Aboulghar
Affiliation:
University of Cairo IVF Centre
Botros Rizk
Affiliation:
University of South Alabama
Get access

Summary

Ovarian stimulation aims at the development of one or more of the ovarian follicles to reach the stage of maturity culminating in the release of one or more mature oocytes ready for fertilization. Ovarian follicular development is under the control of local factors inside the ovaries (most of it is poorly understood), as well as hormones produced from extraovarian sources, mainly pituitary gonadotropins. Other hormones may play a role in ovarian follicular development; the extent and details of such a role are not fully understood.

Type
Chapter
Information
Ovarian Stimulation , pp. 1 - 14
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gemzell, CA, Diczfalusy, E, Tillinger, KG. Clinical effects of human pituitary follicle stimulating hormone FSH. J Clin Endocrinol Metab 1958;18:138–148.CrossRefGoogle ScholarPubMed
Gemzell, CA, Diczfalusy, E, Tillinger, KG. Human pituitary follicle stimulating hormone. 1. Clinical effects of partly purified preparation. Ciba F Coll Endocrin 1960;13:191.Google Scholar
Bettendorf, G, Apostolakis, M, Voigt, KD. Darstellung hochaktiver Gonadotropinfraktionen aus menschlichen Hypophysen und deren anwendung bei Menschen. Proceedings, International Federation of Gynecology and Obstetrics, Vienna 1961:76.Google Scholar
Greenblatt, RB, Barfield, WE, Jungck, EC, Ray, AW. Induction of ovulation with MRL/41. Preliminary report. JAMA 1961;178:101–104.CrossRefGoogle ScholarPubMed
Mitwally, MFM, Casper, RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Abstracts of the 16th Annual Meeting of the European Society for Human Reproduction and Embryology, 2000, Bologna, Italy.Google Scholar
Practice Committee of the American Society for Reproductive Medicine. American Society for Reproductive Medicine, Birmingham, Alabama, USA. Use of clomiphene citrate in women. Fertil Steril 2004;82 Suppl 1:S90–S96.Google Scholar
Mikkelson, TJ, Kroboth, PD, Cameron, WJ, et al. Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril 1986;46:392–396.CrossRefGoogle ScholarPubMed
Young, SL, Opsahl, MS, Fritz, MA. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil Steril 1999;71:639–644.CrossRefGoogle ScholarPubMed
Kerin, JF, Liu, JH, Phillipou, G, Yen, SS. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab 1985;61:265–268.Google Scholar
Kettel, LM, Roseff, SJ, Berga, SL, Mortola, JF, Yen, SS. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril 1993;59:532–538.CrossRefGoogle ScholarPubMed
Garcia, J, Jones, GS, Wentz, AC. The use of clomiphene citrate. Fertil Steril 1977;28:707–717.CrossRefGoogle ScholarPubMed
Athaullah, N, Proctor, M, Johnson, NP. Oral versus injectable ovulation induction agents for unexplained subfertility. Cochrane Database Syst Rev 2002;3:CD003052.Google Scholar
Usadi, RS, Fritz, MA. Induction of ovulation with clomiphene citrate. In: Sciarra, JJ, ed. Gynecology and Obstetrics. Philadelphia: Harper & Row; 1986:Chapter 68.Google Scholar
Purvin, VA. Visual disturbance secondary to clomiphene citrate. Arch Ophthalmol 1995;113:482–484.CrossRefGoogle ScholarPubMed
Maruncic, M, Casper, RF. The effect of luteal phase estrogen antagonism on luteinizing hormone pulsatility and luteal function in women. J Clin Endocrinol Metab 1987;64:148–152.CrossRefGoogle ScholarPubMed
Schenker, JG, Yarkoni, S, Granat, M. Multiple pregnancies following induction of ovulation. Fertil Steril 1981;35:105–123.Google ScholarPubMed
Lipitz, S, Reichman, B, Paret, G, et al. The improving outcome of triplet pregnancies. Am J Obstet Gynecol 1989;161:1279–1284.Google Scholar
Corson, SL, Dickey, RP, Gocial, B, et al. Outcome in 242 in vitro fertilization-embryo replacement or gamete intrafallopian transfer-induced pregnancies. Fertil Steril 1989;51:644–650.CrossRefGoogle ScholarPubMed
Whittemore, AS, Harris, R, Itnyre, J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184–1203.Google Scholar
Rossing, MA, Daling, JR, Weiss, NS, Moore, DE, Self, SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771–776.CrossRefGoogle Scholar
Venn, A, Watson, L, Lumley, J, et al. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995;346:995–1000.CrossRefGoogle ScholarPubMed
Modan, B, Ron, E, Lerner-Geva, L, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038–1042.CrossRefGoogle Scholar
Mosgaard, BJ, Lidegaard, O, Kjaer, SK, Schou, G, Andersen, AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005–1012.CrossRefGoogle ScholarPubMed
Potashnik, G, Lerner-Geva, L, Genkin, L, et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999;71:653.CrossRefGoogle ScholarPubMed
Pike, MC, Pearce, CL, Wu, AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004;23:6379–6391.Google Scholar
Khoo, SK. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?Med J Aust 1986;144:185–190.CrossRefGoogle ScholarPubMed
Fathalla, MF. Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Surv 1972;27:751–768.Google Scholar
Silva I dos, S, Wark, PA, McCormack, VA, et al. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 2009;100:1824–1831.Google Scholar
Scaparrotta, A, Chiarelli, F, Verrotti, A. Potential teratogenic effects of clomiphene citrate. Drug Saf 2017; 40(9):761–769. doi: 10.1007/s40264-017-0546-x.Google Scholar
Reefhuis, J, Honein, MA, Schieve, LA, Rasmussen, SA; National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997–2005. Hum Reprod 2011; 26(2):451–457. doi: 10.1093/humrep/deq313.Google Scholar
Hack, M, Lunenfeld, B. Influence of hormone induction of ovulation on the fetus and newborn. Pediatr Adolesc Endocrinol 1979;5:191.Google Scholar
Correy, JF, Marsden, DE, Schokman, FC. The outcome of pregnancy resulting from clomiphene-induced ovulation. Aust N Z J Obstet Gynaecol 1982;22:18–21.Google Scholar
Whiteman, D, Murphy, M, Hey, K, O’Donnell, M, Goldacre, M. Reproductive factors, subfertility, and risk of neural tube defects: a case-control study based on the Oxford Record Linkage Study Register. Am J Epidemiol 2000;152:823–828.CrossRefGoogle ScholarPubMed
Carlier, P, Choulika, S, Efthymiou, ML. Clomiphene-exposed pregnancies–analysis of 39 information requests including 25 cases with known outcome. Therapie 1996;51:532–536.Google Scholar
Tulandi, T, Martin, J, Al-Fadhli, R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006;85:1761–1765.CrossRefGoogle ScholarPubMed
Dickey, RP, Taylor, SN, Curole, DN, et al. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 1996;11:2642.Google Scholar
Schieve, LA, Tatham, L, Peterson, HB, Toner, J, Jeng, G. Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet Gynecol 2003;101:959–967.Google Scholar
Hakim, RB, Gray, RH, Zacur, H. Infertility and early pregnancy loss. Am J Obstet Gynecol 1995;172:1510–1517.Google Scholar
Franks, S, Adams, J, Mason, H, Polson, D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 1985;12:605–632.CrossRefGoogle ScholarPubMed
Hull, MGR. The causes of infertility and relative effectiveness of treatment. In: Templeton, AA, Drife, JO, eds. Infertility. London: Springer-Verlag; 1992:33–62.Google Scholar
Wysowski, DE. Use of fertility drugs in the United States, 1979 through 1991. Fertil Steril 1993;60:1096–1098.CrossRefGoogle Scholar
Bateman, BG, Nunley, WC Jr, Kolp, LA. Exogenous estrogen therapy for treatment of clomiphene citrate-induced cervical mucus abnormalities: is it effective? Fertil Steril 1990;54:577–579.CrossRefGoogle ScholarPubMed
Ben-Ami, M, Geslevich, Y, Matilsky, M, et al. Exogenous estrogen therapy concurrent with clomiphene citrate–lack of effect on serum sex hormone levels and endometrial thickness. Gynecol Obstet Invest 1994;37(3):180–182.Google Scholar
Gonen, Y, Casper, RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990;5:670–674.CrossRefGoogle ScholarPubMed
Nelson, LM, Hershlag, A, Kurl, RS, Hall, JL, Stillman, RJ. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril 1990;53:727–731.CrossRefGoogle ScholarPubMed
Li, TC, Warren, MA, Murphy, C, Sargeant, S, Cooke, ID. A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women. Br J Obstet Gynaecol 1992;99:1008–1013.Google Scholar
Hammond, MG, Halme, JK, Talbert, LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 1983;62:196–202.Google Scholar
Sereepapong, W, Suwajanakorn, S, Triratanachat, S, et al. Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 2000;73:287–291.Google Scholar
Hsu, CC, Kuo, HC, Wang, ST, Huang, KE. Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility. Obstet Gynecol 1995;86:917–921.Google Scholar
Yoshimura, Y, Hosoi, Y, Atlas, SJ, Wallach, EE. Effect of clomiphene citrate on in vitro ovulated ova. Fertil Steril 1986;45:800–804.Google Scholar
Shimoya, K, Tomiyama, T, Hashimoto, K, et al. Endometrial development was improved by transdermal estradiol in patients treated with clomiphene citrate. Gynecol Obstet Invest 1999;47:251–254.Google Scholar
Gerli, S, Gholami, H, Manna, C, et al. Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study. Fertil Steril 2000;73:85–89.Google Scholar
Wu, CH, Winkel, CA. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 1989;52:564–568.Google Scholar
Saleh, A, Biljan, MM, Tan, SSSL, Tulandi, T. Effects of tamoxifen (Tx) on endometrial thickness and pregnancy rates in women undergoing superovulation with clomiphene citrate (CC) and intrauterine insemination (IUI). Fertil Steril 2000;74:S1–S90.Google Scholar
Unfer, V, Casini, ML, Costabile, L, et al. High dose of phytoestrogens can reverse the antiestrogenic effects of clomiphene citrate on the endometrium in patients undergoing intrauterine insemination: a randomized trial. J Soc Gynecol Investig 2004;11:323–328.CrossRefGoogle ScholarPubMed
Cole, PA, Robinson, CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem 1990;33:2933–2942.CrossRefGoogle ScholarPubMed
Santen, RJ, Manni, A, Harvey, H, Redmond, C. Endocrine treatment of breast cancer in women. Endocrine Rev 1990;11:1–45.CrossRefGoogle ScholarPubMed
Winer, EP, Hudis, C, Burstein, HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2002;20:3317–3327.Google Scholar
Buzdar, A, Jonat, W, Howell, A, et al. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol 1996;14:2000–2011.Google Scholar
Marty, M, Gershanovich, M, Campos, B, et al. Aromatase inhibitors, a new potent, selective aromatase inhibitor superior to aminoglutethimide (AG) in postmenopausal women with advanced breast cancer previously treated with antioestrogens. Proc Am Soc Clin Oncol 1997;16:156.Google Scholar
Mitwally, MFM, Casper, RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol 2000;10:244–247.Google Scholar
Mitwally, MF, Casper, RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305–309.Google Scholar
Mitwally, MF, Casper, RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005;83:229–231.CrossRefGoogle ScholarPubMed
Mitwally, MF, Casper, RF. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Soc Gynecol Investig 2004;11:406–415.Google Scholar
Mitwally, MF, Casper, RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002;77:776–780.CrossRefGoogle ScholarPubMed
Al-Omari, WR, Sulaiman, WR, Al-Hadithi, N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2004;85:289–291.CrossRefGoogle ScholarPubMed
Fatemi, HM, Kolibianakis, E, Tournaye, H, et al. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod Biomed Online 2003;7:543–546.CrossRefGoogle ScholarPubMed
Healey, S, Tan, SL, Tulandi, T, Biljan, MM. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 2003;80:1325–1329.Google Scholar
Mason, AJ, Berkemeier, LM, Schmelzer, CH, et al. Activin B: precursor sequences, genomic structure and in vitro activities. Mol Endocrinol 1989;3:1352–1358.CrossRefGoogle ScholarPubMed
Roberts, V, Meunier, H, Vaughan, J, et al. Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 1989;124:552–554.Google Scholar
Weil, SJ, Vendola, K, Zhou, J, et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1989;837:2479–2485.Google Scholar
Weil, S, Vendola, K, Zhou, J, Bondy, CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951–2956.Google Scholar
Vendola, KA, Zhou, J, Adesanya, OO, Weil, SJ, Bondy, CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622–2629.Google Scholar
Vendola, K, Zhou, J, Wang, J, et al. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 1999;61:353–357.Google Scholar
Giudice, LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992;13:641–669.Google Scholar
Package insert of letrozole Femara®.Google Scholar
Package insert of anastrozole Arimidex®.Google Scholar
Mitwally, MF, Casper, RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med 2004;22:61–78.Google ScholarPubMed
Rubin, GL, Zhao, Y, Kalus, AM, Simpson, ER. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res 2000;60:1604–1608.Google Scholar
Mitwally, MF, Witchel, SF, Casper, RF. Troglitazone: a possible modulator of ovarian steroidogenesis. J Soc Gynecol Investig 2002;9:163–167.Google Scholar
Nirmala, PB, Thampan, RV. Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem Biophys Res Commun 1995;213:24–31.Google Scholar
Rosenfeld, CR, Roy, T, Cox, BE. Mechanisms modulating estrogen-induced uterine vasodilation. Vascul Pharmacol 2002;38:115–125.Google Scholar
Vignali, M, Infantino, M, Matrone, R, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 2002;78:665–678.Google Scholar
Oktay, K, Buyuk, E, Libertella, N, Akar, M, Rosenwaks, Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005;23:4347–4353.Google Scholar
Oktay, K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005;23:3858–3859.CrossRefGoogle ScholarPubMed
Hamilton, A, Piccart, M. The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer. Ann Oncol 1999;10:377–384.Google Scholar
Goss, PE. Risks versus benefits in the clinical application of aromatase inhibitors. Endocr Relat Cancer 1999;6:325–332.CrossRefGoogle ScholarPubMed
Mitwally, MF, Biljan, MM, Casper, RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005;192:381–386.Google Scholar
Tulandi, T, Al-Fadhli, R, Kabli, N, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006;85:1761–1765.CrossRefGoogle ScholarPubMed
Hoffman, JIE. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995;16:103.Google Scholar
Badawy, A, Shokeir, T, Allam, AF, Abdelhady, H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand 2009;88:187–191.CrossRefGoogle ScholarPubMed
Franik, S, Eltrop, SM, Kremer, JA, Kiesel, L, Farquhar, C. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 2018;5:CD010287. doi: 10.1002/14651858.CD010287.pub3.Google ScholarPubMed
Legro, RS, Brzyski, RG, Diamond, MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014;371:119–129.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×